IL-4 Expression by neutrophils in psoriasis lesional skin upon high-dose UVB exposure

Dermatology

Volumn 207, Issue 1, 2003, Pages 51-53

  Piskin, Gamze ^a   Tursen, Umit ^a   Bos, Jan D ^a   Teunissen, Marcel B M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Photoimmunology; Polymorphonuclear cells; Psoriasis; Skin; Th1 Th2 cells; Ultraviolet B

Indexed keywords

CD15 ANTIGEN; ELASTASE; INTERLEUKIN 4;

ADULT; ARTICLE; CASE REPORT; CELL TYPE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; RADIATION DOSE; RADIATION EXPOSURE; SKIN BIOPSY; SKIN DEFECT; ULTRAVIOLET B RADIATION;

ADULT; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; PSORIASIS; RADIATION DOSAGE; REFERENCE VALUES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0038310024     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070942     Document Type: Article

References (14)

1. Ozawa M, Ferenczi K, Kikuchi T, et al: 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999;189:711-718.
2. Piskin G, Koomen CW, Picavet D, Bos JD, Teunissen MBM: Ultraviolet-B irradiation decreases IFN-γand increases IL-4 expression in psoriatic lesional skin in situ and in cultured dermal T cells derived from these lesions. Exp Dermatol, in press.
3. Bos JD, de Rie MA: The pathogenesis of psoriasis: Immunological facts and speculations. Immunol Today 1999;20:40-46.
4. Di Nuzzo S, de Rie MA, van der Loos CM, et al: Solar-simulated ultraviolet irradiation induces selective influx of CD4+ T lymphocytes in normal human skin. Photochem Photobiol 1996;64:988-993.
5. Di Nuzzo S, Sylva-Steenland RMR, Koomen CW, et al: UVB irradiation of normal human skin favors the development of type-2 T-cells in vivo and in primary dermal cell cultures. Photochem Photobiol 2002;76:301-309.
6. 2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 1998; 160:3783-3789.
7. Teunissen MBM, Piskin G, di Nuzzo S, et al: Ultraviolet B radiation induces a transient appearance of IL-4+ neutrophils, which support the development of Th2 responses. J Immunol 2002;168:3732-3739.
8. Hawk JL, Murphy GM, Holden CA: The presence of neutrophils in human cutaneous ultraviolet-B inflammation. Br J Dermatol 1988;118: 127-130.
9. Kang K, Hammerberg C, Meunier L, Cooper KD: CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 1994;153:5256-5264.
10. Austin LM, Ozawa M, Kikuchi T, et al: The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999;113:752-759.
11. De Jong R, Bezemer AC, Zomerdijk TP, et al: Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monome-thylfumarate. Eur J Immunol 1996;26:2067-2074.
12. Bozza M, Bliss JL, Dorner AJ, Trepicchio WL: Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. J Interferon Cytokine Res 2001;21:21-30.
13. Asadullah K, Friedrich M, Hanneken S, et al: Effects of systemic interleukin-10 therapy on psoriatic skin lesions: Histologic, immunohistologic, and molecular biology findings. J Invest Dermatol 2001;116:721-727.
14. Ghoreschi K, Thomas P, Breit S, et al: Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003;9:40-46.